Literature DB >> 8789199

Oxidation of 3,4-dihydroxybenzylamine affords 3,4-dihydroxybenzaldehyde via the quinone methide intermediate.

M Sugumaran1.   

Abstract

Dopamine and related compounds are known to be toxic to melanoma cells. Some of their toxicity may be related, in part, to the oxidation products generated from them upon their interaction with melanogenic enzymes. In this paper, we present our studies on the oxidation chemistry of 3,4-dihydroxybenzylamine, the lower homolog of dopamine. Mushroom tyrosinase catalyzed oxidation of 3,4-dihydroxybenzylamine rapidly generated the corresponding quinone. However, aminomethyl-o-benzoquinone thus formed did not accumulate in the reaction mixture, but readily transformed to another product that exhibited absorbance maxima at 280 and 310 nm. This compound was identified to be 3,4-dihydroxybenzaldehyde based on its HPLC elution profile, cochromatography with authentic sample and UV spectral properties. Possible mechanism for the formation 3,4-dihydroxybenzaldehyde from 3,4-dihydroxybenzylamine and the nature of cytotoxic quninonoid intermediates formed are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789199     DOI: 10.1111/j.1600-0749.1995.tb00671.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  3 in total

1.  Corrosion protection mechanism of Ce4+/organic inhibitor for AA2024 in 3.5% NaCl.

Authors:  Mohamed Gobara; Ahmad Baraka; Robert Akid; Mahmoud Zorainy
Journal:  RSC Adv       Date:  2020-01-10       Impact factor: 4.036

Review 2.  Reactivities of Quinone Methides versus o-Quinones in Catecholamine Metabolism and Eumelanin Biosynthesis.

Authors:  Manickam Sugumaran
Journal:  Int J Mol Sci       Date:  2016-09-20       Impact factor: 5.923

Review 3.  Chemical Reactivities of ortho-Quinones Produced in Living Organisms: Fate of Quinonoid Products Formed by Tyrosinase and Phenoloxidase Action on Phenols and Catechols.

Authors:  Shosuke Ito; Manickam Sugumaran; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.